High variability among Emergency Departments in 3rd-generation cephalosporins and fluoroquinolones use for community-acquired pneumonia

被引：0
|
作者：
Eric Batard
Nathalie Lecadet
Nicolas Goffinet
Jean-Benoit Hardouin
Didier Lepelletier
Gilles Potel
Emmanuel Montassier
机构：
[1] Centre Hospitalier Universitaire de Nantes,Emergency Department
[2] Hôtel-Dieu,Faculté de Médecine and Pharmacie
[3] Université de Nantes,Faculté de Médecine and Pharmacie
[4] EA 3826 Thérapeutiques Cliniques et Expérimentales des Infections,Department of Microbiology and Infection Control
[5] Université de Nantes,undefined
[6] EA 4275 SPHERE Biostatistics Pharmacoepidemiology and Human Science Research Team,undefined
[7] Centre Hospitalier Universitaire de Nantes,undefined
[8] Hôtel-Dieu,undefined
来源：
Infection | 2015年 / 43卷
关键词：
Community-acquired pneumonia; Antibiotic prescription; Prudent use; Cephalosporins; Fluoroquinolones; Emergency department;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：681 / 689
页数：8
相关论文
共 30 条
  • [1] High variability among Emergency Departments in 3rd-generation cephalosporins and fluoroquinolones use for community-acquired pneumonia
    Batard, Eric
    Lecadet, Nathalie
    Goffinet, Nicolas
    Hardouin, Jean-Benoit
    Lepelletier, Didier
    Potel, Gilles
    Montassier, Emmanuel
    INFECTION, 2015, 43 (06) : 681 - 689
  • [2] Increasing use of 3rd-generation cephalosporins for pneumonia in the Emergency Department: may some prescriptions be avoided?
    Goffinet, N.
    Lecadet, N.
    Peron, C.
    Cousin, M.
    Hardouin, J. B.
    Batard, E.
    Montassier, E.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2014, 28 : 102 - 102
  • [3] Use of the respiratory fluoroquinolones for the outpatient management of community-acquired pneumonia
    Liu, HH
    CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 2004, 65 (03): : 225 - 238
  • [4] Approaches to treatment of community-acquired pneumonia in the emergency department and the appropriate role of fluoroquinolones
    Moran, Gregory
    JOURNAL OF EMERGENCY MEDICINE, 2006, 30 (04) : 377 - 387
  • [5] New generation fluoroquinolones and the treatment of adults with community-acquired pneumonia.
    Léophonte, P
    MEDECINE ET MALADIES INFECTIEUSES, 2001, 31 : 648S - 652S
  • [6] Heath Economics of Use Fluoroquinolones to Treat Patients with Community-Acquired Pneumonia
    Restrepo, Marcos I.
    Frei, Christopher R.
    AMERICAN JOURNAL OF MEDICINE, 2010, 123 : S39 - S46
  • [7] Characteristics and epidemiological changes for patients with community-acquired pneumonia in hospital emergency departments
    Julian-Jimenez, A.
    Gonzalez del Castillo, J.
    Martinez Ortiz de Zarate, M.
    Candel Gonzalez, F. J.
    Pinera Salmeron, P.
    Moya Mir, M. S.
    ANALES DEL SISTEMA SANITARIO DE NAVARRA, 2013, 36 (03) : 387 - 395
  • [8] Evaluation of empirical antibiotherapy for acute community-acquired pneumonia prescribed in emergency departments
    Fraisse, T.
    Fayad, G.
    Jardy, C.
    Sotto, A.
    MEDECINE ET MALADIES INFECTIEUSES, 2012, 42 (01): : 5 - 9
  • [9] Clinical experience in the management of community-acquired pneumonia:: lessons from the use of fluoroquinolones
    Carratalá, J
    Martín-Herrero, JE
    Mykietiuk, A
    García-Rey, C
    CLINICAL MICROBIOLOGY AND INFECTION, 2006, 12 : 2 - 11
  • [10] Oseltamivir Use Among Children and Adults Hospitalized With Community-Acquired Pneumonia
    Oboho, Ikwo K.
    Bramley, Anna
    Finelli, Lyn
    Fry, Alicia
    Ampofo, Krow
    Arnold, Sandra R.
    Self, Wesley H.
    Williams, Derek J.
    Courtney, D. Mark
    Zhu, Yuwei
    Anderson, Evan J.
    Grijalva, Carlos G.
    McCullers, Jonathan A.
    Wunderink, Richard G.
    Pavia, Andrew T.
    Edwards, Kathryn M.
    Jain, Seema
    OPEN FORUM INFECTIOUS DISEASES, 2017, 4 (01):
123